Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Mais filtros

Métodos Terapêuticos e Terapias MTCI
Base de dados
Tipo de documento
País de afiliação
Intervalo de ano de publicação
1.
Neurol Sci ; 21(5): 315-7, 2000 Oct.
Artigo em Inglês | MEDLINE | ID: mdl-11286044

RESUMO

Propranolol and primidone are widely used, effective agents in essential tremor although they are not tolerated by all patients. In the present study, the effectiveness of alprazolam, a triazole analog of benzodiazapine class, and acetazolamide, a carbonic anhydrase inhibitor, were investigated as symptomatic treatments for essential tremor. We studied 22 patients with essential tremor in a double-blind, cross-over, placebo-controlled design. The patients received in random order alprazolam, acetazolamide, primidone and placebo for four weeks, each separated by a two-week washout period. The study demonstrated that alprazolam was superior to placebo and equipotent to primidone, whereas there was no statistically significant difference between acetazolamide and placebo. The mean effective daily dose of alprazolam was 0.75 mg and there was not any troublesome side effect reported by the patients on alprazolam. Alprazolam can be used as an alternative agent in elderly essential tremor patients who can not tolerate primidone or propranolol.


Assuntos
Acetazolamida/uso terapêutico , Alprazolam/uso terapêutico , Anticonvulsivantes/uso terapêutico , Tremor Essencial/tratamento farmacológico , Moduladores GABAérgicos/uso terapêutico , Acetazolamida/efeitos adversos , Adulto , Idoso , Idoso de 80 Anos ou mais , Alprazolam/efeitos adversos , Anticonvulsivantes/efeitos adversos , Método Duplo-Cego , Eletromiografia , Tremor Essencial/fisiopatologia , Feminino , Moduladores GABAérgicos/efeitos adversos , Humanos , Masculino , Pessoa de Meia-Idade , Primidona/efeitos adversos , Primidona/uso terapêutico
2.
Abdom Imaging ; 22(4): 389-91, 1997.
Artigo em Inglês | MEDLINE | ID: mdl-9157856

RESUMO

Colonic lipomas are often asymptomatic, but large lipomas may produce abdominal pain, diarrhea, constipation, hemorrhage, and intussusception. We report a young woman with a colonic lipoma who presented as an acute abdominal emergency with total colonic obstruction and severe pain associated with intussusception and extrusion of the tumor through the anus. The case was interesting because of its presentation after a double-contrast barium enema and because of the patient's young age and the tumor's location on the left side of the colon.


Assuntos
Canal Anal/patologia , Sulfato de Bário , Doenças do Colo , Meios de Contraste , Enema , Obstrução Intestinal/etiologia , Intussuscepção/complicações , Lipoma/complicações , Neoplasias do Colo Sigmoide/complicações , Abdome Agudo/etiologia , Doença Aguda , Adulto , Doenças do Colo/diagnóstico por imagem , Enema/efeitos adversos , Feminino , Seguimentos , Humanos , Obstrução Intestinal/diagnóstico por imagem , Intussuscepção/diagnóstico por imagem , Lipoma/diagnóstico por imagem , Radiografia , Neoplasias do Colo Sigmoide/diagnóstico por imagem
3.
Artigo em Inglês | MEDLINE | ID: mdl-8804127

RESUMO

Leukotriene C4 (LTC4) and prostaglandin E2 (PGE2) are known to be highly potent cerebral vasoconstrictors which are formed from arachidonic acid (AA). They enhance vascular permeability, inducing vasogenic edema that may damage the ischemic penumbra after ischemia and reperfusion. The inhibitory effect of aqueous garlic extract (AGE) on AA metabolism in human platelets is known. In this study, following the global ischemic model application to the rats, all underwent 10 min ischemia and were reperfused for different periods. The levels of LTC4 and PGE2 in rat forebrain were then measured. One rat group consisted of 8 rats. In the combined reperfused groups both metabolites increased significantly when compared with the 10 min ischemia alone, no reperfusion group (p < 0.05). In the 8 min reperfused group, PGE2 and LTC4 levels increased significantly at 60 min of reperfusion compared with each corresponding control group (P < 0.005). PGE2 and LTC4 levels were reduced significantly at 60 min of reperfusion compared with the 8 min reperfused group (P < 0.005). AGE (1 ml/kg) reduced both LTC4 and PGE2 levels significantly in the 8 min and 60 min reperfused group (P < 0.001, P < 0.001, P < 0.05, P < 0.01). In conclusion, AGE reduced LTC4 and PGE2 levels at a dosage of 1 ml/kg following 8 and 60 min reperfusion. It may be helpful in reducing AA metabolite levels and preventing injury after ischemic phenomena.


Assuntos
Isquemia Encefálica/metabolismo , Dinoprostona/metabolismo , Alho , Leucotrieno C4/metabolismo , Plantas Medicinais , Prosencéfalo/efeitos dos fármacos , Traumatismo por Reperfusão/metabolismo , Animais , Feminino , Masculino , Extratos Vegetais/farmacologia , Prosencéfalo/metabolismo , Prosencéfalo/patologia , Ratos , Ratos Sprague-Dawley
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA